CRYSTAL-STRUCTURES AT 2.2 A RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND AN ONCOGENIC MUTANT COMPLEXED WITH GDP

被引:239
作者
TONG, L
DEVOS, AM
MILBURN, MV
KIM, SH
机构
[1] UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720
[2] UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,BERKELEY,CA 94720
关键词
D O I
10.1016/0022-2836(91)90753-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biological functions of ras proteins are controlled by the bound guanine nucleotide GDP or GTP. The GTP-bound conformation is biologically active, and is rapidly deactivated to the GDP-bound conformation through interaction with GAP (GTPase Activating Protein). Most transforming mutants of ras proteins have drastically reduced GTP hydrolysis rates even in the presence of GAP. The crystal structures of the GDP complexes of ras proteins at 2.2 Å resolution reveal the detailed interaction between the ras proteins and the GDP molecule. All the currently known transforming mutation positions are clustered around the bound guanine nucleotide molecule. The presumed "effector" region and the GAP recognition region are both highly exposed. No significant structural differences were found between the GDP complexes of normal ras protein and the oncogenic mutant with valine at position 12, except the side-chain of the valine residue. However, comparison with GTP-analog complexes of ras proteins suggests that the valine side-chain may inhibit GTP hydrolysis in two possible ways: (1) interacting directly with the γ-phosphate and altering its orientation or the conformation of protein residues around the phosphates; and/or (2) preventing either the departure of γ-phosphate on GTP hydrolysis or the entrance of a nucleophilic group to attack the γ-phosphate. The structural similarity between ras protein and the bacterial elongation factor Tu suggests that their common structural motif might be conserved for other guanine nucleotide binding proteins. © 1991.
引用
收藏
页码:503 / 516
页数:14
相关论文
共 63 条
[1]   GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN (GAP) INTERACTS WITH THE P21-RAS EFFECTOR BINDING DOMAIN [J].
ADARI, H ;
LOWY, DR ;
WILLUMSEN, BM ;
DER, CJ ;
MCCORMICK, F .
SCIENCE, 1988, 240 (4851) :518-520
[2]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[3]   THE MOLECULAR-GENETICS OF CANCER [J].
BISHOP, JM .
SCIENCE, 1987, 235 (4786) :305-311
[4]   AMINO-ACID SUBSTITUTIONS AT CODON-13 OF THE N-RAS ONCOGENE IN HUMAN ACUTE MYELOID-LEUKEMIA [J].
BOS, JL ;
TOKSOZ, D ;
MARSHALL, CJ ;
VERLAANDEVRIES, M ;
VEENEMAN, GH ;
VANDEREB, AJ ;
VANBOOM, JH ;
JANSSEN, JWG ;
STEENVOORDEN, ACM .
NATURE, 1985, 315 (6022) :726-730
[5]   MECHANISM OF ACTIVATION OF AN N-RAS GENE IN THE HUMAN FIBRO-SARCOMA CELL-LINE HT1080 [J].
BROWN, R ;
MARSHALL, CJ ;
PENNIE, SG ;
HALL, A .
EMBO JOURNAL, 1984, 3 (06) :1321-1326
[6]   CRYSTAL-STRUCTURE OF AN ACTIVE FORM OF RAS PROTEIN, A COMPLEX OF A GTP ANALOG AND THE HRAS P21 CATALYTIC DOMAIN [J].
BRUNGER, AT ;
MILBURN, MV ;
TONG, L ;
DEVOS, AM ;
JANCARIK, J ;
YAMAIZUMI, Z ;
NISHIMURA, S ;
OHTSUKA, E ;
KIM, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4849-4853
[7]   CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS [J].
BRUNGER, AT ;
KURIYAN, J ;
KARPLUS, M .
SCIENCE, 1987, 235 (4787) :458-460
[8]   THE CYTOPLASMIC PROTEIN GAP IS IMPLICATED AS THE TARGET FOR REGULATION BY THE RAS GENE-PRODUCT [J].
CALES, C ;
HANCOCK, JF ;
MARSHALL, CJ ;
HALL, A .
NATURE, 1988, 332 (6164) :548-551
[9]   COMPLETE NUCLEOTIDE-SEQUENCES OF THE T24 HUMAN BLADDER-CARCINOMA ONCOGENE AND ITS NORMAL HOMOLOG [J].
CAPON, DJ ;
CHEN, EY ;
LEVINSON, AD ;
SEEBURG, PH ;
GOEDDEL, DV .
NATURE, 1983, 302 (5903) :33-37
[10]   P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID [J].
CASEY, PJ ;
SOLSKI, PA ;
DER, CJ ;
BUSS, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8323-8327